Wana Brands Partners with AltMed Florida to Bring Medical Cannabis Products to the Sunshine State
Wana Brands' Capsules and Lozenges
Will Soon Be Available to Florida's 138,558 Medical Cannabis Patients
Sarasota, Florida - July 24, 2018 (Investorideas.com Newswire) Florida's medical cannabis patients will soon be able to access the nation's most consistent medical capsules and lozenges, thanks to a partnership between Wana Brands, an experienced producer of marijuana infused products, and the award-winning producer of pharmaceutical grade cannabis products, AltMed Florida.
The agreement will bring Wana Brands' leading line of cannabis-derived medical products to Florida dispensaries, once they receive all required approvals from the Florida Department of Health's Office of Medical Marijuana Use. The products will be available exclusively at AltMed Florida's MüV™ Medical Cannabis Dispensaries.
The products include WanaCapsXR, the world's first slow-release cannabis capsule, which Wana Brands introduced for medical cannabis patients in 2015. With five proprietary extended release formulations available, ranging from High THC to High CBD, WanaCapsXR provide medicinal benefits for 8-12 hours, allowing patient to reduce the frequency of re-dosing. The extended release formula lessens potential side effects such as disorientation and dizziness.
Wana Lozenges will also be available, containing 5mg THC each to enable effective and precise dosing.
This agreement solidifies Wana Brands continued expansion from its Colorado headquarters, where it is the No. 1 infused products cannabis brand, according to BDS Analytics' May 2018 Brandshare Report. The company's popular products are also available in Arizona, Oregon and Nevada dispensaries, with Illinois among the states imminently coming online. Wana Brands expects to expand into California, Maryland, Michigan, Ohio, Pennsylvania, Washington, and internationally in Canada through 2019.
"With our products such as WanaCapsXR, Wana Brands is perfectly positioned to provide reliable and consistent products to Florida's medical marijuana patients," said Nancy Whiteman, Founder & CEO of Wana Brands. "Wana Brands has developed a remarkable line-up of cannabis products that have been built on precision, quality, professionalism and innovation. We have invested in refining our recipes for patients, so that the taste of our products comes through, not the taste of medicine. We look forward to introducing our lozenges and extended-release capsules to the Florida market as well."
"As a national brand and an award-winning customer favorite, Wana Brands is known for its consistent quality and rounds out the portfolio of products offered to our patients," said John Tipton, CEO of AltMed Florida.
Florida's medical cannabis market is expected to grow rapidly and exceed $1 billion by 2020. With a population of 21 million, 19 percent of whom are seniors, Florida is estimated to eventually have hundreds of thousands of medical marijuana patients. The burgeoning system currently has 138,558 registered patients and 1,572 registered physicians, with 400,000 patients forecast by 2020.
Since Florida voters approved medical marijuana in a referendum in November 2016, 14 medical cannabis production licenses have been awarded by the state, and dispensaries began opening across the state once regulations were finalized in November 2017. Each licensee can open 25 dispensaries.
Conditions authorized for medical cannabis use include cancer, ALS, Crohn's Disease, epilepsy, glaucoma, HIV/AIDS, seizures, multiple sclerosis and Parkinson's disease. Floridians are not allowed to grow their own medical marijuana or smoke cannabis flower so rely on companies like Wana and AltMed Florida to provide consistent, safe medicine.
Chewable medical marijuana products are not yet legal in Florida's new medical cannabis market, but with this agreement, Wana Brands and AltMed will be positioned to distribute gummies as new product categories are approved by Florida's Office of Medical Marijuana Use.
For more information or to schedule an interview, please contact Shawna McGregor / Grasslands at 917-971-7852 or firstname.lastname@example.org.
**Product photos available at www.wanabrands.com/assets.**
Wana Brands: Enhance Your Life.
Named The Cannabist People’s Choice Award Winner for Best Edible in January 2018, Wana Brands leads the cannabis infused products industry in quality, consistency and potency. Wana products include a full line of edibles, including its market leading gummies and WanaCapsXR, a family of extended release cannabis capsules that provide symptom relief for up to 12 hours. Wana Brands is the No. 1 ranked edibles brand in sales revenue in the highly competitive Colorado market according to BDS Analytics 2017 Brand Share report. Wana products are also available in Arizona, Oregon and Nevada, with planned entry into California, Florida, Illinois, Maryland, Michigan, Ohio, Pennsylvania, Washington, and internationally in Canada in 2018. For more information, visit www.wanabrands.com. Follow Wana on Facebook, Instagram, LinkedIn and Twitter.
Alternative Medical Enterprises, LLC, headquartered in Sarasota, FL and doing business as AltMed Enterprises, is a fully integrated company that brings pharmaceutical industry precision to the development, production and dispensing of medical cannabinoids.
Grasslands: A Journalism-Minded Agency
Marijuana / Hemp Stocks
Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing
Global Cannabis Investing - features Investor Ideas Cannabis news
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.